WWW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Brand Strength Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline TONX Q1 2026 Earnings Significant EPS Beat Drives 458 Stock Gain Zepp Health Q3 2025 Earnings Loss Per Share of 004 Amidst Market Challenges MED Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Resilience